Santhera Pharmaceuticals Financials
| SANN Stock | CHF 9.25 0.33 3.44% |
Santhera |
Please note, the imprecision that can be found in Santhera Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Santhera Pharmaceuticals Holding. Check Santhera Pharmaceuticals' Beneish M Score to see the likelihood of Santhera Pharmaceuticals' management manipulating its earnings.
Santhera Pharmaceuticals Stock Summary
Santhera Pharmaceuticals competes with Swiss Life, Swiss Re, Helvetia Holding, Partners Group, and Straumann Holding. Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for orphan and other diseases with high unmet medical needs in the European countries. Santhera Pharmaceuticals Holding AG is headquartered in Pratteln, Switzerland. SANTHERA N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 114 people.| Instrument | Switzerland Stock View All |
| Exchange | SIX Swiss Exchange |
| ISIN | CH0027148649 |
| Business Address | Hohenrainstrasse 24, Pratteln, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.santhera.com |
| Phone | 41 61 906 89 50 |
| Currency | CHF - Swiss Franc |
You should never invest in Santhera Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Santhera Stock, because this is throwing your money away. Analyzing the key information contained in Santhera Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Santhera Pharmaceuticals Key Financial Ratios
There are many critical financial ratios that Santhera Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Santhera Pharmaceuticals reports annually and quarterly.Santhera Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Santhera Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Santhera Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Santhera Pharmaceuticals competition to find correlations between indicators driving Santhera Pharmaceuticals's intrinsic value. More Info.Santhera Pharmaceuticals Holding is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Santhera Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Santhera Pharmaceuticals Systematic Risk
Santhera Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Santhera Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Santhera Pharmaceuticals correlated with the market. If Beta is less than 0 Santhera Pharmaceuticals generally moves in the opposite direction as compared to the market. If Santhera Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Santhera Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Santhera Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Santhera Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Santhera Pharmaceuticals December 13, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Santhera Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Santhera Pharmaceuticals Holding. We use our internally-developed statistical techniques to arrive at the intrinsic value of Santhera Pharmaceuticals Holding based on widely used predictive technical indicators. In general, we focus on analyzing Santhera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Santhera Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.16 | |||
| Information Ratio | 0.0121 | |||
| Maximum Drawdown | 9.1 | |||
| Value At Risk | (3.25) | |||
| Potential Upside | 3.62 |
Additional Tools for Santhera Stock Analysis
When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.